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ABSTRACT 
MobiHealth’ aims at introducing new mobile value- 
added services in the area of mobile healthcare, based 
on 2.5 (GPRS) and 3G (UMTS) technologies. This is 
achieved by the integration of sensors and actuators to a 
Wireless Body Area Network (BAN). These sensors and 
actuators continuously measure and transmit vital 
constants along with voice and imagesivideo to health 
service providers and brokers, improving on one side 
the life of patients and allowing on the other side the 
introduction of new value-added services in the areas of 
disease prevention and diagnostic, remote assistance, 
para-health services, physical state monitoring (sports) 
and even clinical research. Furthermore, the MobiHealth 
BAN system supports the fast and reliable application of 
remote assistance in case of accidents by allowing the 
paramedics to send reliable vital constants data as well 
as audio and video directly from the accident site. Trials 
are underway focusing on home care, trauma care and 
ambulatory monitoring. 
1. INTRODUCTION 
Today the health sector faces serious and increasing 
problems in the management of resources for disease 
prevention, follow-up and remote assistance of patients. 
The cost of in-patient care is increasingly creating 
problems for both, patients and social security 
organizations [l]., while out of hospital monitoring of 
the patients’ health state is practically non-existent. The 
patient has either to measure different vital constants at 
regular intervals or has to visit the hospital. As a result, 
patients who need monitoring but are not at immediate 
risk, are obliged to stay for long periods in hospital so 
that regular measurements can he taken. This results in 
high costs for the hospitals and social insurances and in 
the loss of work hours and morale of the patient. 
The introduction of new pan-European mobile health 
and para-health personalized services, based on 2.5 and 
3G technologies will provide new markets and 
opportunities allowing both, citizens and the industry to 
profit. 
I The MobiHealth (No IST-2001-36006) proiect is 
The EU MobiHealth project (IST-2001-36006) is 
bringing together expertise and technologies including 
Body Area Networks (B.4Ns), vital signs sensors and 
wireless communication:; to provide mobile health 
services for patients and for health professionals. 
MobiHealth proposes new services that will allow the 
monitoring of vital constants for out of hospital patients. 
Moreover, MobiHealth improves current practice by 
allowing continuous monitoring of constants such as 
pulse rate, temperature, etc, whereas today, these 
measurements are sampled at intervals only. 
The objective of the MobiHealth project is to develop 
and trial a generic Body Area Network for health 
monitoring using 2.5/3G for extra-BAN 
communication. Patients’ biosignals are measured by 
the BAN and transmitted to a remote healthcare 
location. The MobiHealth trials focus on home care, 
trauma care and ambulatory monitoring. MobiHealth 
trials involve BANS for patients (such as the patient 
trauma BAN) and for health professionals (e.g. nurse or 
paramedic BAN). 
In OUI definition, a Body Area Network is “a collection 
of (inter) communicating devices which are worn on the 
body, providing an integrated set of personalised 
services to the user” [2]. When the devices of a BAN 
measure physiological signals or perform other actions 
for health-related purposes we call this kind Body Area 
Network a health BAN. Communication within a BAN 
may be either wired or wireless, or any combination of 
the two, and is known ais intra-BAN communication. 
Communication between a. BAN and another network is 
known as extra-BAN communication. 
2. PROJECT APPROACH 
The overall objective of the project is the introduction 
of new mobile health seivices, based on the on-line, 
continuous monitoring of vital signs, via GPRS and 
UMTS technologies (Figure 1). These services are 
supported by the Mobilfealth Body Area Network 
(BAN), a wireless system that will allow the simple 
connection of different viral signal sensors. The BAN, 
the GPRSAJMTS infrastruchlres, as well as the new 
services are tested via a set of trials conducted in 
different European countries. , .  - 
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ordination, (local) computation functions and 
communication. (Figure 2). 
Figure 1 Generic MobiHealth System 
Thesc trials provide the context in which both the 
medical advantages and business perspectives of the 
new mobile health services are demonstrated and 
evaluated. 
Since health related data and information is highly 
protected by law and by professional ethics the 
MobiHealth project takes all reasonable measures to 
protect information relating to patients and users. In this 
context MobiHealth aims at defining a harmonized 
protection framework, based on EU reference directives 
~ 3 1 .  
3. PROJECT IMPLEMENTATION 
3. I .  Functional Description 
The MobiHealth trials implement simple, but complete 
services that can be immediately deployed over the 
UMTS and GPRS networks. The MobiHealth 
patientiuser is equipped with different interoperating or 
independent vital constant sensors, ranging from blood 
pressure and pulse rate, to oxygen saturation and 
electrocardiograms (ECG). In addition images and 
video can be captured and transmitted to the health 
center. 
The vital constant measurements are sent to a health 
broker (which may be a hospital or a medical call 
center), where specialists are able to observe the 
evolution of the patient and intervene when needed. The 
communication is based on 2.5 ~ 3G wireless 
technologies. 
The use of GPRS and UMTS as communication 
technology is essential due to the need for wide 
coverage and continuous connection to the healthcare 
center. 
3.2 MobiHealth BAN architecture. 
The generic MobiHealth BAN architecture consists of a 
central unit called the MBU (Mobile Base Unit) plus a 
set of devices, which may include sensors, actuators, 
and various multimedia devices. The MBU handles co- 
I I 
Figure 2 MobiHeolth BAN orchitecture 
The MBU used currently in the MobiHealth trials is 
based on the HP iPAQ platform, with plans to port also 
to other platforms such as the Sony Ericsson P800 
phone in future. The BAN Operating System (BAN OS) 
provides the local functionality offered by the MBU. 
The BAN OS consists of a native OS, such as Linux or 
Windows CE, a Java virtual machine and a set of 
generic functions implemented in Java, referred to as 
BANware. 
Figure 3 shows the hardware and software components 
of the MobiHealth BAN and its environment. The 
surrogate host acts as an intermediary between the 
applications in the E-health domain and the MobiHealth 
domain. The surrogate host executes a surrogate object 
to represent each BAN. A surrogate object shields 
applications in the E-health domain from temporary 
disruptions in the wireless networks, in addition it offers 
a Lookup Service (LUS) which enables lookup and 
discovery of active BANS. The .surrogate objects are 
defined according to the Jini Surrogate architecture, 
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Figure 3. Components ofthe MobiHealth BAN and its 
environment 
Sensor data is transmitted to the MBU via a sensor 
front-end. The front-end is a device that digitizes the 
analogue signals from the sensors and transmits this 
information to the MBU. 
3729 
MobiHealfh BAN Devices. During the MobiHealth 
project the BANs are customized for each trial with a 
different sensor set. For example we can make a BAN 
for cardiac monitoring by attaching a miniature 
wearable (3-lead) ECG monitor. The electrodes are 
sensors which convert chemical concentration 
differences from ions into an electrical potential. 
Additional sensors can be attached to measure oxygen 
saturation and NIBP (non invasive blood pressure). 
Heart rate can be calculated from the ECG. 
For other applications other sensor sets are used 
incorporating for example pulse oximeters and motion 
sensors. 
3.3 MobiHealth Intra-BAN Communications. 
The MobiHealth concept allows for wired or wireless 
communications within the BAN, or a combination of 
the two. Bluetooth [4] and Zigbee [SI currently are the 
wireless technologies of choice for intra-BAN 
communication. The choice of communication 
technology partly depends on the application and the 
sensor sets involved, such as the amount of data that a 
sensor set produces and the power consumption needed 
for a certain communication technology. 
3.4 MobiHealth Extra-BAN Communications 
For the MobiHealth trials extra-BAN communication is 
mainly based on GPRS. Transmission speeds in GPRS 
networks depend on the type of terminal used and 
settings (controlled by an operator) in the GPRS 
network, and may be asymmetrical (i.e. uplink and 
downlink speeds may differ). Terminals can either be 
GPRS phones (e.g. Nokia 6310 or Sony Ericsson P800) 
or PC cards. Transmission speeds vary from 
14.4/28.8kbps uplink and 28.8/43.2kbps downlink. In 
the MobiHealth project the GPRS phone acts as a 
‘wireless modem’. The MBU communicates via 
Bluetooth to the GPRS phone. The GPRS phone uses an 
asymmetrical transmission scheme (14.4kpbs uplink and 
43.2kbps downlink) and forwards the information to the 
GPRS network. It is also possible to use a GPRS PC 
card in combination with the MobiHealth MBU, 
integrating external communication technology in the 
BAN. Transmission speeds are symmetrical and are 
limited to 28.8kbps. In order to abstract from wireless 
transmission technology, BAN to Intemet 
communication, and vice versa, is based on the IP 
protocol. 
When UMTS becomes available (2003/2004), initial 
transmission speeds will vary from 64kbps to 144kbps. 
During the MohiHealth project lifecycle UMTS 
availability is likely to be limited to test sites only. The 
availability of a first generation UMTS network will 
broaden the application suite which can be supported by 
the BAN. 
4. VALIDATION OF MOBIHEALTH APPROACH 
A central point of the MobiHealth project is the 
assessment and evaluation of the trials. The trial results 
are validated with different medical applications from 
four points of view. First, the accuracy and validity of 
the measurements taken Iby the MobiHealth BAN will 
be validated. This will1 be done by comparing 
MobiHealth measurements with those measurements 
captured using current mt:thods. Secondly, the usability 
and suitability of the GPRSLJMTS networks to support 
the MobiHealth application requirements will he tested. 
For this, network-related (:vents like change of operator 
or UMTS-GPRS hand-over will be registered and the 
effects on the MobiHealth services will be measured 
(delays, loss of data, bandwidth problems, security 
issues, etc.). Thirdly, the business and market potential 
for the new services will be defined. Related costs will 
be measured and compared with actual traditional 
methods. Subjective opinions of users and organizations 
regarding the new seriices, their usefulness and 
usability will be collected. The fourth and last issue here 
concems emerging ethical questions. Evaluation will 
include the effects of prevention and the intervention on 
the person or the family. 
Different scenarios with different requirements are 
trialed involving a sufficiently large number of users, so 
that credible results can be drawn. A total of four trial 
sites has been set up in different countries, involving 
different health centers (The Netherlands, Sweden, 
Germany, Spain). The trials cover a range of clinical 
conditions and take place in different settings (the 
patient’s home, outdoors :and, for the trauma setting, at 
the scene of the accidenl. and in the ambulance) and 
cover use of patient BANs and health professional 
BANs (nurse BAN, paramedic BAN). The trials are also 
selected to represent a range of bandwidth requirements 
and to include both non-realtime and realtime 
requirements. The overall goal is to test the ability of 
2.5 and 3G infrastructui:es to support value added 
services. 
4. I Telemonitoring of patients with ventricular 
arrhythmia. 
In Germany the MobiHealth system will be tested and 
evaluated with a cohort of patients suffering from 
ventricular arrhythmias who are undergoing drug 
therapy for this condition. In such patients, ECG 
measurements have to be taken regularly to monitor 
efficacy of drug therapy. In this trial the patient BAN 
transmits ECG and blood pressure via GPRS to a 
Medical Service Centre, where the vital signs are 
monitored by physicians and nurses. From a health 
economic point of view the intervention is expected to 
save time and reduce costs. Main outcome parameters 
are the number of hospitalizations, drug prescription and 
the levels of blood pressun: and ECG. 
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4.2 Integrated Homecare in women with high-risk 
pregnancies. 
This Dutch trial will use the MobiHealth BAN to 
support Integrated Homecare for women with high-risk 
pregnancies. Women with high-risk pregnancies are 
often admitted to hospital because of possible 
pregnancy-related complications. Homecare with 
continuous monitoring of women with high-risk 
pregnancies, when feasible, is desirable and can 
postpone hospitalisation and reduce costs. In this trial, 
patients are monitored from home using the MobiHealth 
BAN and matemal and foetal signs are transmitted to 
the hospital. For the healthcardmedical evaluation, 
main outcome parameters are the number of days in 
hospital, the number of emergency interventions, patient 
satisfaction with hospital or telemonitoring and the 
reliability of the system to monitor the patients and to 
inform the gynaecologist regarding CTG /ECG and 
EMG data. 
4.3 Support of home-based healihcare services 
This Spanish trial involves use of GPRS for supporting 
home-based care for elderly chronically ill patients 
including remote assistance if needed. Trial subjects 
suffer from co-morbidities which include Chronic 
Obstructive Pulmonary Disease. The MobiHealth 
.Nurse-BAN will be used to perform patient 
measurements during nurse home visits and the 
MobiHealth patient-BAN will he used for continuous 
home monitoring and also outdoors during patient 
rehabilitation. Physical parameters to be measured are 
Oxygen saturation, ECG, spirometry, temperature, 
glucose and blood pressure. 
4.4 Home care and remote consuliation for recently 
releasedpatients in a rural area. 
In this Swedish trial the trial subjects are patients with 
multiple chronic diseases including cardiac failure, 
diabetes and respiratory disability who have been 
recently discharged from hospital and who are living at 
home in a low population density rural area. 
Measurements (including blood pressure, heart rate, 
oxygen saturation and blood glucose, as appropriate) are 
transmitted to a remote physician or a registered district 
nurse (RDN). The healthcardmedical evaluation will 
focus on qualitative instruments measuring user 
experiences of the intervention by the involved roles: 
staff, patients and their next-of-kin. 
5. CONCLUSION 
MobiHealth represents the convergence of different 
technologies to enable personalized, mobile health 
services. The function of a BAN is to integrate all the 
wearable devices such as PDA’s mobile phones and 
watches that a person carries around during the day. 
The innovation of MobiHealth lies on the integration of 
these technologies in a flexible and generic system - the 
MobiHealth BAN - with the development of the 
required software that will provide an open platform for 
the creation of new, personalized services in the arza of 
mobile health. The MobiHealth BAN, being generic, 
can be easily customized to provide services to the 
sports community, the medical research community, to 
the study of causes and triggers in chronic diseases (e.g. 
asthma or epilepsy) and to the detection and prevention 
of serious acute events (e.g. sudden infant death, stroke, 
etc.). 
Finally, it is considered to be important to also point out 
to the technological and medical risks of MobiHealth. 
Technological risks include e.g. radio interference or 
interference with medical equipment. Medical risks may 
be possible health effects that the new technology might 
introduce to the patients, e.g. possible electromagnetic 
hazards associated with cell phone usage. The in-depth 
study of these risks is out of the scope of the project, 
nevertheless, risks will be identified and the project will 
take into consideration possible consequences and 
integrate existing solutions to cope with the related 
issues. 
5.1 Status of theproject 
The project started in May 2002 and will be completed 
in November 2003. At the time of writing (may 2003) 
the project is about to start the trials at the four sites. 60 
health-BAN sets are under implementation bared on the 
HP (previously Compaq) iPAQ and will be delivered to 
the users in early June 2003. 
The IntraBan communications of the 60 health BANS 
are based on Bluetooth. 
The evaluation methodology and the detailed trial 
scenarios have been defined, while pre-trials are 
underway at the different sites. The trials will last 6 
months and an evaluation on both at the medical and 
technological results will be performed. More 
information on the project status and results can be 
found at the project site (http://www.mobihealth.org). 
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